Pharmacy groups’ motion for preliminary injunction denied in Medco-Express Scripts case
U.S. District Judge Cathy Bissoon has denied a motion for preliminary injunction raised by retail pharmacy groups challenging Express Scripts’ purchase of Medco Health Solutions. Judge Bissoon found that plaintiffs were unable to show the likelihood of immediate, irreparable harm. The harm that they did allege–displaced management and the exchange of confidential information and trade secrets between Medco and Express Scripts–was found to have already happened because of the two companies’ integration plan of July 2011. Morever, Judge Bissoon found that a temporary injunction would render Medco unable to compete with Express Scripts, as nearly all of Medco’s senior management has already been terminated.
Featured News
DOJ Considers Reviving Collaboration Guidelines to Clarify Antitrust Rules
Mar 25, 2026 by
CPI
JetBlue Weighs Sale to Rival Airlines Amid Strategic Review
Mar 25, 2026 by
CPI
Chile Approves Joint Codelco–Anglo American Copper Project
Mar 25, 2026 by
CPI
Bernie Sanders Unveils Bill to Ban Data Centers Until Congress Passes AI Regulation
Mar 25, 2026 by
CPI
CFTC Unveils New Task Force to Focus on AI, Crypto, Prediction Markets
Mar 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers